Sanjiban Pharma

LupiHer2 (Pertuzumab) 420mg/14ml injection is a prescription anticancer medication, specifically a humanized monoclonal antibody, used in the treatment of HER2-positive breast cancer. It works by binding to the HER2 receptor, which inhibits the growth of cancer cells and aids in their destruction. LupiHer2 is typically administered intravenously by a healthcare professional, often in combination with other drugs like trastuzumab and chemotherapy. 

• Metastatic HER2-positive breast cancer: In combination with trastuzumab and docetaxel for patients who have not previously received anti-HER2 therapy or chemotherapy for their metastatic disease.
• Neoadjuvant Treatment (Before Surgery): For HER2-positive, locally advanced, inflammatory, or early-stage breast cancer to shrink tumors before surgery.
• Adjuvant Treatment (After Surgery): For early-stage HER2-positive breast cancer that has a high risk of recurrence. 

Additional Information:

• Delivery Time: Within city half an hour
• Packaging Details: vial

Pertuza (Pertuzumab Injection, 420mg/14ml) is a targeted anti-cancer medication used to treat HER2-positive breast cancer, including metastatic, locally advanced, inflammatory, or early-stage, typically in combination with trastuzumab and chemotherapy. It works by binding to HER2 receptors, inhibiting tumor growth, and is administered intravenously, usually every three weeks. 

• HER2-Positive Metastatic Breast Cancer: Used for patients who have not received prior anti-HER2 therapy or chemotherapy.
• Neoadjuvant Treatment: Used before surgery for early-stage or locally advanced breast cancer to shrink tumors.
• Adjuvant Treatment: Used after surgery for HER2-positive early-stage breast cancer at high risk of recurrence.
• Mechanism: As a biosimilar, Pertuza targets the HER2 protein on cancer cells, inhibiting cell proliferation. 

Additional Information:

• Delivery Time: WITH IN CITY HALF AN HOUR
• Packaging Details: VIA;

Pertuzumab is used to treat certain types of breast cancer. It is also used to treat early stage breast cancer in patients who will be having surgery to remove the cancer.